Risk Michael C, Masterson Timothy A
Department of Urology, Indiana University School of Medicine, Indianapolis, IN, USA.
Indian J Urol. 2010 Jan-Mar;26(1):64-71. doi: 10.4103/0970-1591.60454.
Intratubular germ cell neoplasia (ITGCN) is the precursor lesion for invasive testicular germ cell tumors (TGCTs) of adolescents and young adults. The rising incidence of these tumors has prompted a rigorous investigation of the etiology, diagnosis and management of ITGCN. Bilateral testicular cancer is closely linked with ITGCN, as patients with unilateral testicular cancer are at the highest risk for a future malignancy in the contralateral testicle.
A literature review directed at ITGCN and bilateral testis cancer was performed using the Medline/PubMed database. Our review focused on the pathogenesis, risk factors, diagnosis and treatment regimens utilized.
Major advances have been made in the understanding of ITGCN over the past 30 years. There is evidence that TGCTs arise from ITGCN, ITGCN is closely related to fetal gonocytes, and that events in pre- and perinatal period may result in abnormal persistence of fetal gonocytes leading to ITGCN and subsequent TGCT. Controversy exists regarding the need to biopsy men at increased risk of TGCT, as well as the best approach to managing patients with known ITGCN. Bilateral testicular cancer has excellent outcomes in the current era of platinum-based chemotherapy.
The optimal management of patients at risk for ITGCN and future TGCT is still a matter of debate. Individualization of management, including biopsy and treatment, should be based on risk factors for TGCT, compliance with potential surveillance, and patient preferences particularly with regard to fertility.
小管内生殖细胞瘤(ITGCN)是青少年和年轻男性侵袭性睾丸生殖细胞肿瘤(TGCT)的前驱病变。这些肿瘤发病率的上升促使人们对ITGCN的病因、诊断和管理进行了严格的研究。双侧睾丸癌与ITGCN密切相关,因为单侧睾丸癌患者对侧睾丸未来发生恶性肿瘤的风险最高。
使用Medline/PubMed数据库对ITGCN和双侧睾丸癌进行文献综述。我们的综述重点关注其发病机制、危险因素、诊断和治疗方案。
在过去30年里,对ITGCN的认识取得了重大进展。有证据表明TGCT起源于ITGCN,ITGCN与胎儿生殖母细胞密切相关,围产期及出生前期的一些事件可能导致胎儿生殖母细胞异常持续存在,进而导致ITGCN及后续的TGCT。对于TGCT风险增加的男性是否需要进行活检,以及已知ITGCN患者的最佳管理方法仍存在争议。在当前基于铂类化疗的时代,双侧睾丸癌的治疗效果良好。
对于有ITGCN风险和未来发生TGCT风险的患者,最佳管理方案仍存在争议。管理的个体化,包括活检和治疗,应基于TGCT的危险因素、对潜在监测的依从性以及患者的偏好,尤其是在生育方面的偏好。